SCHEMBL22775960

SCHEMBL22775960

CCS(=O)(=O)c1nn2cccnc2c1-c1nc2cc(C(F)(F)F)ccc2n1C

nearest known ligand 0.43

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
▸ KCNQ3 O43525 4/20 0.40
▸ KCNQ2 O43526 4/20 0.40
▸ NPC1 O15118 1/20 0.38
▸ RAB9A P51151 1/20 0.38
▸ CA12 O43570 1/20 0.36
▸ CA9 Q16790 1/20 0.36
▸ PDE2A O00408 2/20 0.36
▸ RORC P51449 1/20 0.35
▸ AGPAT2 O15120 1/20 0.35
▸ S1PR1 P21453 2/20 0.35
▸ CNR2 P34972 2/20 0.34
▸ KIT P10721 1/20 0.34
▸ PDE10A Q9Y233 1/20 0.33
▸ PTGS2 P35354 1/20 0.33
▸ HTR3E A5X5Y0 1/20 0.33
▸ KDM4E B2RXH2 1/20 0.33
▸ HTR3B O95264 1/20 0.33
▸ TP53 P04637 1/20 0.33
▸ CYP1A2 P05177 1/20 0.33
▸ CYP3A4 P08684 1/20 0.33

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL22775915 0.86 POLB (0.41) KCNQ3KCNQ2RAB9AS1PR1PDE10A
SCHEMBL22775955 0.85 NPC1 (0.34) KCNQ3KCNQ2NPC1RAB9ACA12
SCHEMBL29525337 0.85 NPC1 (0.34) KCNQ3KCNQ2NPC1RAB9ACA12
SCHEMBL29526184 0.82 KCNQ3 (0.38) KCNQ3KCNQ2NPC1RAB9APDE2A
SCHEMBL22775559 0.79 AGPAT2 (0.36) NPC1PDE2ARORCAGPAT2CNR2
SCHEMBL14678205 0.75 DDR1 (0.42) NPC1RAB9ACA12CA9PDE2A
SCHEMBL28701103 0.73 POLB (0.38) RAB9AS1PR1KDM4ETP53TSHR
SCHEMBL28679591 0.72 POLB (0.39) NPC1RAB9APTGS2KDM4EGRIN1
SCHEMBL22775838 0.72 HPGD (0.35) NPC1RAB9ACA12CA9S1PR1
SCHEMBL29525530 0.72 HPGD (0.35) NPC1RAB9ACA12CA9S1PR1

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 10 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
EP-3983411-B1 FUSED HETEROCYCLIC COMPOUNDS AND THEIR USE AS PEST CONTROL AGENTS PI INDUSTRIES LTD (IN) 2026-05-27 — — EP claimed
US-12384787-B2 Fused heterocyclic compounds and their use as pest control agents PI INDUSTRIES LTD (IN) 2025-08-12 — — US claimed
US-20220251094-A1 FUSED HETEROCYCLIC COMPOUNDS AND THEIR USE AS PEST CONTROL AGENTS PI INDUSTRIES LTD. (IN) 2022-08-11 — — US claimed
EP-3983411-A1 FUSED HETEROCYCLIC COMPOUNDS AND THEIR USE AS PEST CONTROL AGENTS PI Industries Ltd. (IN) 2022-04-20 — — EP claimed
WO-2020250183-A1 FUSED HETEROCYCLIC COMPOUNDS AND THEIR USE AS PEST CONTROL AGENTS PI INDUSTRIES LTD. (IN) 2020-12-17 — — WO claimed
EP-3983411-B1 FUSED HETEROCYCLIC COMPOUNDS AND THEIR USE AS PEST CONTROL AGENTS PI INDUSTRIES LTD (IN) 2026-05-27 — — EP disclosed
US-12384787-B2 Fused heterocyclic compounds and their use as pest control agents PI INDUSTRIES LTD (IN) 2025-08-12 — — US disclosed
US-20220251094-A1 FUSED HETEROCYCLIC COMPOUNDS AND THEIR USE AS PEST CONTROL AGENTS PI INDUSTRIES LTD. (IN) 2022-08-11 — — US disclosed
EP-3983411-A1 FUSED HETEROCYCLIC COMPOUNDS AND THEIR USE AS PEST CONTROL AGENTS PI Industries Ltd. (IN) 2022-04-20 — — EP disclosed
WO-2020250183-A1 FUSED HETEROCYCLIC COMPOUNDS AND THEIR USE AS PEST CONTROL AGENTS PI INDUSTRIES LTD. (IN) 2020-12-17 — — WO disclosed

Patent text — is the patent's own abstract consistent with the prediction?

For each of this compound's patents that has machine-readable text (2 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.

PatentTitleText reads most aboutPredicted target · text-rank
US-12384787-B2 Fused heterocyclic compounds and their use as pest control agents DDT, ACHE, KEAP1 KCNQ3 487/4885KCNQ2 179/4885NPC1 3338/4885
US-20220251094-A1 FUSED HETEROCYCLIC COMPOUNDS AND THEIR USE AS PEST CONTROL AGENTS DDT, ACHE, KEAP1 KCNQ3 487/4885KCNQ2 179/4885NPC1 3338/4885

“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.

Send feedback